ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

4-Methylmorpholine → (R)-methyl 3-((2-(3-(2-ethoxyphenoxy)piperidin-1-yl)pyrimidine-5-carboxamido)methyl)benzoate

HRID 59905
印刷

反応式

HRID 59905 の反応式
Cl.[NH2:2][CH2:3][C:4]1[CH:5]=[C:6]([CH:11]=[CH:12][CH:13]=1)[C:7]([O:9][CH3:10])=[O:8].CN1CCOCC1.CCN=C=NCCCN(C)C.Cl.C1C=CC2N(O)N=NC=2C=1.[CH2:43]([O:45][C:46]1[CH:67]=[CH:66][CH:65]=[CH:64][C:47]=1[O:48][C@@H:49]1[CH2:54][CH2:53][CH2:52][N:51]([C:55]2[N:60]=[CH:59][C:58]([C:61](O)=[O:62])=[CH:57][N:56]=2)[CH2:50]1)[CH3:44]>C1COCC1.CS(C)=O>[CH2:43]([O:45][C:46]1[CH:67]=[CH:66][CH:65]=[CH:64][C:47]=1[O:48][C@@H:49]1[CH2:54][CH2:53][CH2:52][N:51]([C:55]2[N:60]=[CH:59][C:58]([C:61]([NH:2][CH2:3][C:4]3[CH:5]=[C:6]([CH:11]=[CH:12][CH:13]=3)[C:7]([O:9][CH3:10])=[O:8])=[O:62])=[CH:57][N:56]=2)[CH2:50]1)[CH3:44]
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

8

反応物 5

HCID 79724-MethylmorpholineHCID 757711-HydroxybenzotriazoleHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2794825Methyl 3-(aminomethyl)benzoate HydrochlorideHCID 118366221(R)-2-(3-(2-ethoxyphenoxy)piperidin-1-yl)pyrimidine-5-carboxylic acid

生成物 1

HCID 118366276
(R)-methyl 3-((2-(3-(2-ethoxyphenoxy)piperidin-1-yl)pyrimidine-5-carboxamido)methyl)benzoate
収率 74.5%

試薬・触媒・溶媒 2

HCID 679Dimethyl Sulfoxide溶媒HCID 8028Tetrahydrofuran溶媒

反応条件

温度
15 °C

実験手順

To a 500-mL 3-neck flask was added methyl 3-(aminomethyl)benzoate hydrochloride (12.9 g, 64.1 mmol) followed by DMSO (26 mL). The solution was cooled to 15° C. N-Methyl morpholine (27 mL, 240 mmol) was added followed by EDCl (13 g, 68 mmol) and HOBT (4.09 g, 30 mmol), maintaining the temperature at 15° C. A solution of (R)-2-(3-(2-ethoxyphenoxy)piperidin-1-yl)pyrimidine-5-carboxylic acid (20.94 g, 60.98 mmol) in THF (100 mL) was added dropwise over 10 min. The reaction mixture was warmed to 20-25° C. and stirred for 4 hours. The reaction mixture was concentrated under reduced pressure, and the residue was partitioned between water (200 mL) and pentane-ethyl acetate (1:2, 300 mL). The aqueous phase was further extracted with ethyl acetate (2 times with 100 mL). The combined organic extracts were rinsed sequentially with water (200 mL), saturated aqueous sodium bicarbonate solution (2 times with 100 mL), and brine (2 times with 25 mL). The organic layer was then dried over sodium sulfate, filtered, and concentrated to afford (R)-methyl 3-((2-(3-(2-ethoxyphenoxy)piperidin-1-yl)pyrimidine-5-carboxamido)methyl)benzoate (22.3 g). MS (ES+) 491.3 (M+H).

後処理

  1. temperaturemaintaining the temperature at 15° C
  2. temperatureThe reaction mixture was warmed to 20-25° C.
  3. concentrationThe reaction mixture was concentrated under reduced pressure
  4. customthe residue was partitioned between water (200 mL) and pentane-ethyl acetate (1:2, 300 mL)
  5. extractionThe aqueous phase was further extracted with ethyl acetate (2 times with 100 mL)
  6. washThe combined organic extracts were rinsed sequentially with water (200 mL), saturated aqueous sodium bicarbonate solution (2 times with 100 mL), and brine (2 times with 25 mL)
  7. dry with materialThe organic layer was then dried over sodium sulfate
  8. filtrationfiltered
  9. concentrationconcentrated

出典と根拠

ORDレコード
ord-3980f80b95d54813af43c984dd55e2ae
出典データセット
uspto-grants-2016_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09440949B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート